EG24845A - Pharmaceutical combinations of cox-2 inhibitors and opiates - Google Patents

Pharmaceutical combinations of cox-2 inhibitors and opiates

Info

Publication number
EG24845A
EG24845A EGNA2004000074A EG24845A EG 24845 A EG24845 A EG 24845A EG NA2004000074 A EGNA2004000074 A EG NA2004000074A EG 24845 A EG24845 A EG 24845A
Authority
EG
Egypt
Prior art keywords
opiates
cox
inhibitors
pharmaceutical combinations
pharmaceutical
Prior art date
Application number
Other languages
English (en)
Inventor
Michael Christian Norris
Original Assignee
Adcock Ingram Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Adcock Ingram Ltd filed Critical Adcock Ingram Ltd
Application granted granted Critical
Publication of EG24845A publication Critical patent/EG24845A/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/485—Morphinan derivatives, e.g. morphine, codeine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/5415—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with carbocyclic ring systems, e.g. phenothiazine, chlorpromazine, piroxicam
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Pain & Pain Management (AREA)
  • Reproductive Health (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Dermatology (AREA)
  • Endocrinology (AREA)
  • Neurosurgery (AREA)
  • Emergency Medicine (AREA)
  • Rheumatology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pregnancy & Childbirth (AREA)
  • Immunology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
EGNA2004000074 2002-02-19 2004-08-19 Pharmaceutical combinations of cox-2 inhibitors and opiates EG24845A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
ZA200201395 2002-02-19
PCT/IB2003/000500 WO2003070251A1 (en) 2002-02-19 2003-02-14 Pharmaceutical combinations of cox-2 inhibitors and opiates

Publications (1)

Publication Number Publication Date
EG24845A true EG24845A (en) 2010-10-21

Family

ID=27758232

Family Applications (1)

Application Number Title Priority Date Filing Date
EGNA2004000074 EG24845A (en) 2002-02-19 2004-08-19 Pharmaceutical combinations of cox-2 inhibitors and opiates

Country Status (20)

Country Link
US (1) US20050090517A1 (de)
EP (2) EP2050453B1 (de)
JP (1) JP2005519936A (de)
CN (1) CN100418533C (de)
AP (1) AP1862A (de)
AT (2) ATE524186T1 (de)
AU (1) AU2003208485B2 (de)
CA (1) CA2476939C (de)
CY (1) CY1108839T1 (de)
DE (1) DE60325020D1 (de)
DK (1) DK1478366T3 (de)
EG (1) EG24845A (de)
ES (2) ES2376500T3 (de)
IL (2) IL163637A0 (de)
NZ (1) NZ535500A (de)
OA (1) OA12778A (de)
PT (2) PT1478366E (de)
SI (1) SI1478366T1 (de)
WO (1) WO2003070251A1 (de)
ZA (1) ZA200407485B (de)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2007530620A (ja) * 2004-04-01 2007-11-01 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング メロキシカムを含む組成物
JP2008501655A (ja) * 2004-06-04 2008-01-24 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング メロキシカム含有組成物
ITMI20060983A1 (it) * 2006-05-18 2007-11-19 Formevet S P A Composizioni farmaceutiche veterinarie per il trattamento del dolore e dell'inifiamazione
WO2007138466A2 (en) * 2006-06-01 2007-12-06 Wockhardt Ltd Pharmaceutical compositions comprising meloxicam and tramadol combination
US20080031950A1 (en) * 2007-04-27 2008-02-07 Nectid Inc. Novel anelgesic combination
US20080026054A1 (en) * 2007-04-27 2008-01-31 Nectid Inc. Novel anelgesic combination
EP2177215A1 (de) 2008-10-17 2010-04-21 Laboratorios Del. Dr. Esteve, S.A. Co-Kristalle von Tramadol und NSARs
EP2311446A1 (de) * 2009-10-16 2011-04-20 Laboratorios Del. Dr. Esteve, S.A. Zusammensetzungen, die Tramadol und Celecoxib umfassen, zur Behandlung von Schmerzen
IT1398321B1 (it) * 2010-02-26 2013-02-22 Formevet Spa Ora Formevet Srl Associazione tra un analgesico ad azione centrale e un antinfiammatorio inibitore selettivo della cicloossigenasi 2 per il trattamento dell'infiammazione e del dolore in campo veterinario
EP2392319A1 (de) * 2010-06-04 2011-12-07 Laboratorios Del. Dr. Esteve, S.A. Pharmazeutische Zusammensetzung enthaltend Cokristalle aus Tramadol und einem Coxib
WO2015004505A1 (es) * 2013-07-11 2015-01-15 More Pharma Corporation, S. De R.L. De C.V. Combinación sinergística de paracetamol/celecoxib para el tratamiento de dolor inflamatorio
MX2018013070A (es) 2017-12-29 2019-10-15 Gruenenthal Gmbh Combinación farmacéutica que comprende clorhidrato de tramadol de liberación extendida y etoricoxib de liberación inmediata, y su uso para el tratamiento del dolor.
US20210346328A1 (en) * 2018-09-21 2021-11-11 The Johns Hopkins University Compositions and methods for treating metabolic disorders
CN115300515A (zh) * 2022-08-11 2022-11-08 南京红地生物科技有限公司 一种含有美洛昔康和盐酸曲马多的长效注射液

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA845785B (en) * 1983-06-10 1985-03-27 Adcock Ingram Lab Ltd Pharmaceutical unit
ZA893422B (en) * 1988-02-24 1991-01-30 Adcock Ingram Lab Ltd Pharmaceutical composition
AU3990895A (en) * 1995-12-05 1997-06-27 Adcock Ingram Limited Pharmaceutical composition comprising a skeletal muscle relaxant, a non-steroidal antiinflammatory agent and an analgesic
RS49982B (sr) * 1997-09-17 2008-09-29 Euro-Celtique S.A., Sinergistička analgetička kombinacija analgetičkog opijata i inhibitora ciklooksigenaze-2
FR2770131A1 (fr) * 1997-10-27 1999-04-30 Union Pharma Scient Appl Nouvelle association pharmaceutique a activite analgesique
US6375957B1 (en) * 1997-12-22 2002-04-23 Euro-Celtique, S.A. Opioid agonist/opioid antagonist/acetaminophen combinations
EP2266564B1 (de) * 1997-12-22 2013-03-13 Euro-Celtique S.A. Peroral zu verabreichende Arzneiform enthaltend eine Kombination von einem opioid Agonisten und einem opioid Antagonisten
MXPA02010764A (es) * 2000-05-31 2003-03-10 Warner Lambert Co Combinaciones de un antagonista del receptor endotelina y un compuesto antiepileptico que tiene propiedades para aliviar el dolor o analgesico.
ATE511844T1 (de) * 2000-06-13 2011-06-15 Wyeth Llc Analgetische und entzündungshemmende zusammensetzungen enthaltend celecoxib und ibuprofen

Also Published As

Publication number Publication date
NZ535500A (en) 2006-09-29
CA2476939C (en) 2012-08-28
ES2376500T3 (es) 2012-03-14
EP2050453A1 (de) 2009-04-22
AU2003208485B2 (en) 2009-05-28
US20050090517A1 (en) 2005-04-28
CN1646133A (zh) 2005-07-27
JP2005519936A (ja) 2005-07-07
AU2003208485A1 (en) 2003-09-09
IL163637A0 (en) 2005-12-18
WO2003070251A1 (en) 2003-08-28
DK1478366T3 (da) 2009-03-30
AP2004003134A0 (en) 2004-09-30
PT2050453E (pt) 2012-01-03
AP1862A (en) 2008-07-07
CY1108839T1 (el) 2014-07-02
DE60325020D1 (de) 2009-01-15
EP2050453B1 (de) 2011-09-14
ES2318113T3 (es) 2009-05-01
IL163637A (en) 2010-11-30
EP1478366B1 (de) 2008-12-03
CN100418533C (zh) 2008-09-17
CA2476939A1 (en) 2003-08-28
ZA200407485B (en) 2005-12-28
ATE524186T1 (de) 2011-09-15
PT1478366E (pt) 2009-03-10
EP1478366A1 (de) 2004-11-24
ATE415971T1 (de) 2008-12-15
SI1478366T1 (sl) 2009-06-30
OA12778A (en) 2006-07-06

Similar Documents

Publication Publication Date Title
AU2003303128A8 (en) Inhibitors and methods of use thereof
PL375052A1 (en) Pharmaceutical pig and method of use
EP1615623A4 (de) Orale sicherheitsdosierformen und anwendungsverfahren dafür
AU2003235676A1 (en) Tricyclic-bis-enone derivatives and methods of use thereof
PL378294A1 (pl) Pochodne izochinolinowe i sposoby ich stosowania
EP1594467A4 (de) Missbrauch verhindernde pharmazeutische zusammensetzungen von opioiden und anderen medikamenten
AU2003275311A1 (en) Solid micro-perforators and methods of use
AU2003217870A8 (en) Pini-modulating compounds and methods of use thereof
IL173936A0 (en) Heterocyclic inhibitors of mek and methods of use thereof
ZA200500680B (en) Quinoline derivatives and their use as mycrobacterial inhibitors
AU2003213673A8 (en) Pin1-modulating compounds and methods of use thereof
IL177650A0 (en) Isoquinoline derivatives and methods of use thereof
EP1827391A4 (de) Dosierformen und anwendungsverfahren
EG24845A (en) Pharmaceutical combinations of cox-2 inhibitors and opiates
GB0608398D0 (en) Pharmaceutical composition and method of using same
PL374581A1 (en) Diaminothiazoles and use thereof as cdk4 inhibitors
AU2003210983A8 (en) Kinase inhibitors and methods of use thereof
IL172752A0 (en) Cox-2 and faah inhibitors
AU2003299815A1 (en) Matriptase inhibitors and methods of use
IL176772A0 (en) Acylaminothiazole derivatives and use thereof as beta-amyloid inhibitors
AU2003226496A1 (en) Pharmaceutical combination of the cox-2 inhibitor etodolac and opioids
AU2003251513A8 (en) Rsk inhibitors and therapeutic uses thereof
AU2003287802A1 (en) Palpometer and methods of use thereof
AU2003279800A8 (en) Sulfatases and methods of use thereof
EP1663229A4 (de) Pharmazeutische kombinationen von hydrocodon und naltrexon